| Authors: |
Eckernäs E; Unit for Pharmacokinetics and Drug Metabolism, Department of Pharmacology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden., Bendrioua A; Unit for Pharmacokinetics and Drug Metabolism, Department of Pharmacology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden., Cancellerini C; Unit for Pharmacokinetics and Drug Metabolism, Department of Pharmacology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden., Timmermann C; Centre for Psychedelic Research, Division of Psychiatry, Department of Brain Sciences, Imperial College London, UK., Carhart-Harris R; Centre for Psychedelic Research, Division of Psychiatry, Department of Brain Sciences, Imperial College London, UK., Hoffmann KJ; Unit for Pharmacokinetics and Drug Metabolism, Department of Pharmacology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden., Ashton M; Unit for Pharmacokinetics and Drug Metabolism, Department of Pharmacology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden. Electronic address: michael.ashton@gu.se. |